ZUKITNA
Live / Allowed — Published for opposition (as of 12 Mar 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 14 Apr 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99135835
- Mark type
- Stylized text
- Filed
- 14 Apr 2025
- Published for opposition
- 14 Oct 2025
- Attorney of record
- Gabriel M. Gillmeyer
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of systemic mastocytosis and gastrointestinal stromal tumors mediated by a c-kit or mutant c-kit protein kinase
Owner
- Cogent Biosciences, Inc., Waltham, MA, US
- Cogent Biosciences, Inc., Waltham, MA, US
Prosecution history
- 07 Feb 2026 — EXAMINER'S AMENDMENT ENTERED
- 07 Feb 2026 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 07 Feb 2026 — EXAMINERS AMENDMENT E-MAILED
- 07 Feb 2026 — EXAMINERS AMENDMENT -WRITTEN
- 31 Jan 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 31 Jan 2026 — NON-FINAL ACTION E-MAILED
- 31 Jan 2026 — NON-FINAL ACTION WRITTEN
- 31 Jan 2026 — PREVIOUS ALLOWANCE COUNT WITHDRAWN
- 29 Jan 2026 — CASE RETURNED TO EXAMINATION
- 29 Jan 2026 — NOTICE OF ALLOWANCE CANCELLED
- 09 Dec 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 14 Oct 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 14 Oct 2025 — PUBLISHED FOR OPPOSITION
- 08 Oct 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 16 Sept 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER